🔍 Definition
Atherosclerosis is a chronic, systemic inflammatory disease of the arterial wall characterized by the progressive accumulation of lipid-laden plaques (atheromas) within the intima of medium- and large-caliber arteries. The process begins with endothelial dysfunction, followed by lipoprotein infiltration, macrophage recruitment, foam cell formation, fibrous cap development, and ultimately plaque vulnerability, ulceration, rupture, or calcification. The result is progressive luminal narrowing, reduced arterial compliance, and—when plaques become unstable—acute thrombotic events including myocardial infarction, stroke, and limb ischemia.
Per the FY2026 ICD-10-CM Tabular List, atherosclerosis is classified primarily under category I70 (Atherosclerosis), with subcategories organized by vessel territory (aorta, renal artery, extremity arteries, bypass grafts). Related cerebrovascular and coronary manifestations are coded under I65–I67 and I25, respectively. This guide addresses the systemic (general) spectrum of atherosclerosis; for coronary artery disease see the CAD CDG (I25.x), and for peripheral arterial disease of the lower extremities see the PVD CDG (I70.2xx).
🗂️ Alternative Terminology
The following terms are commonly encountered in clinical documentation and each maps to specific ICD-10-CM codes. Coders must query when the term is ambiguous or when a more specific anatomical code is available.
| Formal / ICD-10 Term | Colloquial / Lay / Clinical Synonyms |
|---|---|
| Atherosclerosis (I70.x) | Hardening of the arteries, arteriosclerosis, arterial plaque disease, atheromatous disease |
| Atherosclerosis of aorta (I70.0) | Aortic atherosclerosis, aortic calcification, aortic plaque |
| Atherosclerosis of renal artery (I70.1) | Renovascular disease, renal artery stenosis (atherosclerotic) |
| Atherosclerosis of extremity arteries (I70.2xx–I70.7xx) | Peripheral artery disease (PAD), peripheral vascular disease (PVD), lower extremity arterial disease (LEAD) |
| Generalized atherosclerosis (I70.91) | Diffuse atherosclerosis, systemic atherosclerosis, multivessel atherosclerosis |
| Chronic total occlusion of artery of extremities (I70.92) | CTO, total occlusion, complete arterial blockage |
| Cerebral atherosclerosis (I67.2) | Intracranial atherosclerosis, cerebrovascular atherosclerosis (chronic, non-infarct) |
| Carotid stenosis without infarction (I65.01–I65.09) | Carotid artery disease, carotid plaque, extracranial carotid atherosclerosis |
| Coronary artery disease (I25.10/I25.11x) | CAD, coronary atherosclerosis, ischemic heart disease — see CAD CDG |
I73.9 (Peripheral vascular disease, unspecified) carried an HCC in the v24 model but was removed from HCC mapping in v28. A claim coded only to I73.9 generates zero RAF. When documentation says "PVD," query for site, laterality, and severity so the more specific I70.2xx code (which does map to HCC 263/264/266) can be assigned. This is one of the highest-impact CDI opportunities in vascular coding.
🩺 Signs & Symptoms
Clinical presentation of atherosclerosis varies by vessel territory. Many patients are asymptomatic until significant luminal stenosis (>70%) or plaque rupture occurs. Common presentations include:
- Cardiovascular: Exertional chest pain/angina (CAD), dyspnea on exertion, palpitations; acute MI when plaque ruptures in coronary territory
- Cerebrovascular: Transient ischemic attack (TIA), amaurosis fugax, focal neurological deficits, stroke (when carotid/vertebral stenosis causes embolism or perfusion failure)
- Peripheral (lower extremity): Intermittent claudication, rest pain, non-healing wounds/ulcers, gangrene; cold, pale, or mottled extremities; diminished or absent pedal pulses; reduced ankle-brachial index (ABI)
- Renal: Renovascular hypertension (refractory to multiple antihypertensives), progressive chronic kidney disease, flash pulmonary edema (Pickering syndrome)
- Aortic: Often asymptomatic; may present with abdominal/back pain if aneurysmal dilation occurs; mesenteric ischemia (post-prandial pain, weight loss) in visceral artery involvement
- Mesenteric: Abdominal angina, weight loss, post-prandial pain
Physical exam findings include carotid bruits, diminished peripheral pulses, prolonged capillary refill, trophic skin changes (hair loss, shiny skin, nail dystrophy), and funduscopic evidence of retinal arterial narrowing. Ankle-brachial index (ABI) <0.9 is diagnostic for PAD per ACC/AHA guidelines.
🧭 Differential Diagnosis
| Condition | Distinguishing Features | Key ICD-10-CM Code(s) |
|---|---|---|
| Thromboangiitis obliterans (Buerger disease) | Young smokers; small/medium vessels; affects hands and feet; inflammatory; no atherosclerotic risk factors | I73.1 |
| Raynaud phenomenon | Episodic vasospasm triggered by cold/stress; color changes (white → blue → red); no fixed stenosis | I73.00, I73.01 |
| Vasculitis (Takayasu, giant cell arteritis) | Inflammatory markers elevated; constitutional symptoms; younger patients (Takayasu); ESR/CRP markedly elevated; biopsy diagnostic | M31.4, M31.5, M31.6 |
| Acute arterial embolism/thrombosis | Sudden onset "6 Ps"; cardiac source (A-fib, valvular); no prior claudication history | I74.3, I74.4, I74.5 |
| Diabetic peripheral neuropathy | Symmetric distal sensory loss; normal or preserved pulses; ABI normal; burning pain vs. claudication | E11.40, E11.41 |
| Lumbar spinal stenosis (neurogenic claudication) | Pain relieved by forward flexion; reproduces with standing not just walking; normal ABI; MRI diagnostic | M48.06, M48.07 |
| Chronic venous insufficiency | Venous stasis ulcers (medial malleolus); varicosities; normal ABI; dependent edema | I87.2, I87.31x |
| Fibromuscular dysplasia | Young women; beaded appearance on angiography; renal/carotid arteries; no plaque | I77.3 |
📋 Clinical Indicators for Coders/CDI
The following clinical indicators support the diagnosis and assignment of atherosclerosis codes. Documentation in the medical record should reflect these findings to justify code assignment and support HCC capture.
| Indicator | Clinical Significance | CDI Action |
|---|---|---|
| ABI <0.9 (ankle-brachial index) | Objective confirmation of PAD; ABI 0.71–0.9 = mild, 0.41–0.70 = moderate, ≤0.40 = severe | Query for I70.2xx with severity; document laterality |
| Arterial duplex with significant stenosis (>50%) | Imaging confirmation of plaque burden and flow reduction | Ensure anatomical specificity; document "atherosclerosis" not just "stenosis" |
| CTA/MRA showing calcified/non-calcified plaque | Cross-sectional imaging captures plaque in aorta, iliofemoral, renal, carotid territories | Link radiologic finding to clinical diagnosis in attending notes |
| Carotid IMT >1.0 mm on ultrasound | Surrogate marker for subclinical atherosclerosis; indicates systemic burden | Support coding of I67.2 or I65.x if carotid plaque is present |
| History of bypass graft surgery (CABG, aortofemoral, femoropopliteal) | Indicates prior severe atherosclerotic disease; graft-specific atherosclerosis codes apply post-operatively | Assign I70.3xx–I70.7xx for graft disease; Z95.1 or Z95.828 for graft presence |
| Non-healing arterial ulcer / gangrene | Critical limb ischemia; substantially higher HCC weight (ulceration/gangrene subcodes under I70.2xx) | Query for severity classification; avoid I73.9 |
| Refractory hypertension with renal bruit | Suggests atherosclerotic renal artery stenosis (I70.1); may require captopril renogram or renal duplex | Query attending for "atherosclerosis of renal artery" |
| Statin therapy + antiplatelet therapy | Indicates known atherosclerotic cardiovascular disease (ASCVD); Z79.82 for aspirin use | Verify primary atherosclerosis diagnosis is present; code Z79.82 |
When the record reflects atherosclerotic burden in multiple territories (aorta, coronary, carotid, peripheral), but each is documented separately, consider querying the provider: "Based on the clinical evidence of atherosclerotic disease in multiple arterial territories, can you document whether the patient has generalized atherosclerosis (I70.91)?" This code maps to HCC 266 and validates the systemic nature of disease for risk adjustment.
🦴 Anatomy & Pathophysiology
Atherosclerosis affects large- and medium-sized arteries. The primary affected vessel territories, their ICD-10 classifications, and clinical relevance are:
- Aorta (I70.0): The aorta is the most common site for early plaque deposition, particularly the abdominal aorta near the renal ostia and iliac bifurcation. Aortic atherosclerosis increases the risk of aneurysmal dilation, peripheral embolism, and serves as the proximal source for iliac/femoral disease.
- Renal arteries (I70.1): Ostial and proximal renal artery plaques cause renal artery stenosis, reducing renal perfusion, activating the renin-angiotensin-aldosterone system (RAAS), and producing renovascular hypertension. Progressive stenosis leads to ischemic nephropathy.
- Extremity arteries (I70.2xx–I70.7xx): The infrainguinal territory (superficial femoral, popliteal, tibial arteries) is most commonly involved. Disease severity ranges from asymptomatic stenosis to intermittent claudication, rest pain, tissue loss (ulceration), and gangrene—classified as Fontaine stages I–IV or Rutherford categories 0–6.
- Carotid/cerebral arteries (I65.x, I66.x, I67.2): Extracranial carotid bifurcation plaques are the most common source of embolic stroke. Intracranial atherosclerosis (I66.x) causes ischemic stroke by thrombosis or hemodynamic compromise. Cerebral atherosclerosis (I67.2) represents chronic non-infarct intracranial disease.
Pathophysiologic cascade per Libby et al., NEJM:
- Endothelial dysfunction — Risk factors (hypertension, dyslipidemia, diabetes, smoking) impair NO production and upregulate adhesion molecules (VCAM-1, ICAM-1).
- LDL oxidation and subendothelial accumulation — LDL particles penetrate the intima and undergo oxidative modification.
- Monocyte recruitment and foam cell formation — Monocytes migrate into the intima, differentiate into macrophages, engulf oxidized LDL, and become lipid-laden foam cells forming the fatty streak.
- Smooth muscle cell migration and fibrous cap formation — Cytokines drive VSMCs from media to intima, producing a fibrous cap that may stabilize or destabilize the plaque.
- Plaque vulnerability and rupture — Thin-cap fibroatheromas with large lipid cores and inflammatory infiltrates are prone to rupture, triggering acute thrombosis and clinical events (MI, stroke, acute limb ischemia).
- Calcification — Dystrophic calcification of necrotic cores can increase plaque rigidity; coronary artery calcium (CAC) scoring quantifies burden.
💊 Medication Impact / Treatment
Pharmacological management of atherosclerosis targets primary risk factors and plaque stabilization. The following drug classes are most relevant for coders and CDI specialists:
| Drug Class | Examples | Coding Relevance |
|---|---|---|
| HMG-CoA reductase inhibitors (statins) | Atorvastatin, rosuvastatin, simvastatin, pravastatin | Primary ASCVD prevention & treatment; J-codes apply for injectables; oral statins → Part D NDC billing; presence confirms atherosclerosis diagnosis |
| PCSK9 inhibitors | Evolocumab (Repatha), alirocumab (Praluent) | HCPCS J0172 (evolocumab), J0173 (alirocumab); used for high-risk ASCVD or statin-intolerant patients; confirms atherosclerotic diagnosis |
| Antiplatelet agents | Aspirin, clopidogrel, ticagrelor, prasugrel | Z79.82 (long-term aspirin use); confirms ASCVD diagnosis for HCC validation; dual antiplatelet therapy (DAPT) suggests post-intervention status |
| ACE inhibitors / ARBs | Lisinopril, ramipril, losartan, valsartan | Cardioprotective in ASCVD; also used for renovascular hypertension (I70.1) |
| Beta-blockers | Metoprolol, carvedilol, bisoprolol | Post-MI, heart failure, and angina management; does not directly affect atherosclerosis coding but supports clinical context |
| Cilostazol / Pentoxifylline | Pletal, Trental | Specifically for PAD claudication; presence strongly supports I70.2xx assignment |
| GLP-1 agonists / SGLT-2 inhibitors | Semaglutide, empagliflozin | Proven ASCVD benefit in diabetics; presence supports E11.51–E11.59 codes alongside I70.x |
| Anticoagulants | Rivaroxaban (low-dose), warfarin | Rivaroxaban 2.5 mg BID + aspirin (COMPASS regimen) used for symptomatic PAD; Z79.01 (long-term anticoagulant use) |
Interventional/surgical treatments (relevant for procedure coding) include endovascular revascularization (angioplasty, stenting, atherectomy), bypass surgery (aortofemoral, femoropopliteal, tibial), carotid endarterectomy (CEA), renal artery stenting, and aortic grafting. These are addressed in the CPT section below.
Preview ends here. The full guide continues with FY2026 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO Members.
← Back to All Clinical Documentation Guides
🔒 Register or sign in to read the full guide
Unlock the full guide including:
- • 📘 ICD-10-CM Guidelines (FY2026)
- • 🔢 ICD-10-CM Code Set (FY2026)
- • 🔎 Indexing
- • 🏥 CPT (2026)
- • 🧾 HCPCS (2026)
- • 📚 AHA Coding Clinic (Recent Guidance)
- • 💰 HCC / Risk Adjustment (v28)
- • ✍️ CDI Query Templates
- • 🧑⚕️ Treatments (Clinical)
- • 🎓 Patient Education / Summary